The INCA trial (Impact of NOD2 genotype-guided antibiotic prevention on survival in patients with liver Cirrhosis and Ascites): study protocol for a randomized controlled trial

BACKGROUND: Patients with liver cirrhosis have a highly elevated risk of developing bacterial infections that significantly decrease survival rates. One of the most relevant infections is spontaneous bacterial peritonitis (SBP). Recently, NOD2 germline variants were found to be potential predictors...

詳細記述

保存先:
書誌詳細
出版年:Trials
主要な著者: Casper, Markus, Mengel, Martin, Fuhrmann, Christine, Herrmann, Eva, Appenrodt, Beate, Schiedermaier, Peter, Reichert, Matthias, Bruns, Tony, Engelmann, Cornelius, Grünhage, Frank, Lammert, Frank
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2015
主題:
Study Protocol
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4359533/
https://ncbi.nlm.nih.gov/pubmed/25887140
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-015-0594-4
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料